The Brazil high-level disinfectants and terminal sterilization services market size was valued at USD 1.48 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.7% from 2021 to 2028. The increasing prevalence of hospital-acquired infections (HAIs) has fueled the demand for high-level disinfectants and terminal sterilization services in Brazil. In addition, the sudden and severe outbreak of COVID-19 has increased significant demand for advanced healthcare facilities, and services to treat the infected. As one of the crucial parts of healthcare, sterilization and disinfection products are experiencing high demand from Brazilian markets to handle the surge of COVID-19 patients. High-level disinfectants and sterilization equipment play an important role in preventing the spread of COVID-19 in healthcare settings. This is expected to provide plenty of high-growth opportunities for market players in the coming years.
Moreover, considering the higher demand for sterilization and disinfection, the Brazilian government and corporations are providing easy regulatory approval and permission to new products utilized in the COVID-19 pandemic. This is expected to help cater to the growing demand for high-level disinfectants and terminal sterilization services in Brazil market. In May 2020, the U.S. Agency for International Development announced USD 6.0 million in humanitarian aid to Brazil for emergency activities in water, health, sanitation, and hygiene and to ease the health impact of COVID-19 in the country.
In Brazil, HAIs are among the major causes of death in hospitalized patients. According to a survey conducted by the Healthcare Infection Society, in 2018, the overall prevalence of ICU-acquired infections was higher in Brazilian hospitals than that reported in the U.S. and most European countries. Such cases are expected to increase the demand for high-level disinfectants and terminal sterilization services in Brazilian hospitals. These products are essential for sterilization and cleaning of different equipment/devices used in hospitals, which help in reducing the transmission of infections and diseases. This is expected to boost the growth of the market in Brazil.
Moreover, the increasing application of the sterilization process in the pharmaceutical and biotechnology industry is expected to fuel the market growth during the forecast period. Sterilization of pharmaceutical manufacturing equipment and packaging is essential to kill all forms of microbial life. Steam sterilization is the best and most commonly used method for sterilization in the pharmaceutical industry at present. In order to ensure products, remain sterile, terminal sterilization is done, which is the process of sterilizing a product in its final container. Henceforth, an increase in R&D activities results in increased demand for various sterilization processes in the pharmaceutical and biotechnology industry. These factors are anticipated to increase the application of sterilization equipment, thus boosting the market growth.
Furthermore, the high prevalence of diseases, such as typhoid, cholera, food poisoning, dengue, and hepatitis A, primarily due to the lack of home cleanliness, is one of the major factors expected to fuel the market growth during the forecast period. For instance, according to the WHO report in 2019, over 1.5 million cases of dengue virus were reported in Brazil, out of which more than 1.02 million occurred in the southeast region of the country, while chikungunya and Zika viruses caused 132,205 and 10,768 cases, respectively. The highest number of dengue fever cases was reported in São Paulo, with nearly 445,000 cases. Such diseases are mainly caused by bacteria and viruses, which thrive in unhealthy home environments and unhygienic toilets and kitchens. Thus, the application of disinfectant solutions is an essential requirement to maintain home as well as public place cleanliness.
An upsurge in the incidence of chronic diseases, such as diabetes, cancer, and other autoimmune diseases, is anticipated to boost the demand for high-level disinfectants and terminal sterilization services in Brazil. Antimicrobial resistance, increased adoption of unhealthy and sedentary lifestyles, smoking, and alcohol consumption are some of the major factors contributing to the growing prevalence of chronic diseases. According to World Heart Federation Report 2017, cardiovascular disorders are estimated to account for nearly three-quarters (74%) of the total adult deaths in Brazil. Moreover, the rising prevalence of obesity in Brazil is resulting in more people developing type 2 diabetes (8.8% of women and 7.4% of men are living with diabetes). Thus, the rising prevalence of chronic conditions has significantly increased hospital admission rates in Brazil. This is expected to positively impact the market growth during the forecast period.
Moreover, the rising number of surgical procedures in Brazil is expected to drive the demand for high-level disinfectants and terminal sterilization services. For instance, as per the International Society of Aesthetic Plastic Surgery (ISAPS), in 2018, Brazil is the country with the most surgical procedures, performed nearly 2,267,405 cosmetic/aesthetic procedures (both surgical and nonsurgical). Sterilizing equipment is vital for every hospital, laboratory, and clinic to prevent infections during and after the procedure. Therefore, effective and thorough sterilizing of medical equipment is necessary to avoid the risk of cross-contamination leading to infections. Thus, the aforementioned factors are expected to boost the market growth over the forecast period.
The aldehydes segment dominated the market with a share of 29.61% in 2020. This can be attributed to the high prevalence of healthcare-associated infections in Brazilian hospitals (particularly in ICUs). Aldehyde disinfectants are generally employed during endoscopic processes and reprocessing of surgical units. Aldehydes are among the most commonly used compounds for disinfecting surgical equipment. Thus, the rising number of surgical procedures in Brazil and HAIs caused due to the improper reprocessing of surgical units are expected to drive the demand for these products. Thus, the segment is anticipated to grow lucratively over the forecast period.
The chlorine compounds segment is expected to expand at the highest CAGR of 9.20% from 2021 to 2028. The rise in the incidence of water-borne and food-borne diseases due to the lack of proper hygiene in Brazil is one of the major reasons driving the segment. For instance, as per the Department of Health Surveillance, Brazilian Ministry of Health, there were around 13,163 outbreaks of food-borne diseases in Brazil between 2000 and 2018. Chlorine compounds are considered the most effective disinfectants due to their strong oxidizing properties. These products are generally used in the disinfection of water and hard surfaces. Such instances are, therefore, expected to boost the demand for chlorine disinfectants.
In 2020, the hospitals segment dominated the market with a share of 54.00% and is expected to expand at the highest CAGR from 2021 to 2028. An increase in the incidence of hospital-acquired infections, a rise in the number of surgical procedures, and a continuously growing patient pool in Brazil are the key factors driving the segment. The usage of suitable disinfectants and sterilization methods are essential as these help in preventing the transmission of infections.
Moreover, an increase in the volume of surgical procedures in clinics is a major factor contributing to the clinics segment growth. Maintaining proper hygiene and sanitation is necessary to maintain a healthy environment in the clinic. In addition, the spread of COVID-19 requires the adoption of preventive measures for containing the spread of disease, therefore, clinics are undertaking preventive measures. These factors are expected to drive the adoption of disinfection and sterilization services in clinics, thereby boosting the segment growth over the forecast period.
In 2020, the ethylene oxide (EtO) segment dominated the market with a share of 34.96%. EtO has been widely utilized as a low-temperature sterilization technique since the early 20th century and has been found to be compatible with most medical devices and materials. This sterilization technique is used as an alternative to steam/dry heat for sterilizing moisture-intolerant or heat-sensitive surgical equipment and supplies in healthcare facilities. Thus, items/devices that cannot endure extreme temperature and humidity can be treated by this technique, thus boosting the segment growth.
The moist heat sterilization segment is expected to expand at the highest CAGR of 9.30% from 2021 to 2028. Over the past decade, these techniques have been increasingly accepted owing to their applications in the dairy and pharmaceutical industry and R&D organizations. Advantages of using heat sterilization methods, such as the ability to sterilize liquid substances, nontoxicity, and their inexpensive nature, are boosting the penetration of these techniques in the market. Moreover, moist heat sterilization is widely used in all hospitals and clinics to disinfect medical equipment, such as surgical scalpels. Thus, the aforementioned factors are expected to help the segment maintain its growth over the forecast period.
New product launches and strategic alliances are the key undertakings of the participants in this vertical. For instance, in March 2019, Getinge launched the latest 9100E Cart Washer. It is designed to reduce clinical, operational, and financial risks faced by hospitals with its fast cycle time of only 10 minutes.
Companies are involved in partnerships and mergers& acquisitions to expand their product portfolio, increase their manufacturing capacities, and provide competitive diversity. For instance, in April 2019, Fortive Corporation acquired Johnson & Johnson's Advanced Sterilization Products business (a division of Ethicon, Inc.) for an aggregate value of around USD 2.8 billion. Thus, infection prevention-related product portfolio would be marketed under Fortive. Similarly, in February 2020, Nordion, Inc. and Westinghouse Electric Company signed a contract to develop advanced isotope production technology, which would allow Cobalt-60 to be produced in Pressurized Water Reactors. Through this alliance, both the companies will bolster the supply of Cobalt-60. This product plays an important role in reducing pathogens in food and other products and decontamination of medical devices. Some prominent players in the Brazil high-level disinfectants & terminal sterilization services market include:
ASP (Fortive Corporation)
Sterigenics U.S., LLC (Sotera Health Company)
Baumer S. A.
CISA Production S.R. L.
Souza & Filhos
Fonseca Servicos De Outsourcing
Brazil Cleaning Services
Mudanjiang Plasma Physical Application Technology Co., Ltd. (CASP)
Laoken Technology Co. Ltd.
GFE do Brasil
Choyang Medical Industry Ltd.
Market size value in 2021
USD 1.87 billion
Revenue forecast in 2028
USD 3.36 billion
CAGR of 8.7% from 2021 to 2028
Base year for estimation
2016 - 2019
2021 - 2028
Revenue in USD million/billion and CAGR from 2021 to 2028
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Compound, type, end-use
Key companies profiled
ASP (Fortive); Limpidus; Morhena Group; Steris Plc; Sigex; BSS (Hospitalar); Souza & Filhos; Fonseca Servicos De Outsourcing; Sterigenics U.S., LLC (Sotera Health Company); Getinge AB; Cantel Medical; 3M; Brazil Cleaning Services; Matachana Group; Baumer S. A.; CISA Production S.R. L.; Mudanjiang Plasma Physical Application Technology Co., Ltd. (CASP); Laoken Technology Co. Ltd.; Olympus Corporation; Lifemed; Endoclear; GFE do Brasil; Choyang Medical Industry Ltd.; Steelco S.p.A
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country & segment scope
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the Brazil high-level disinfectants & terminal sterilization services market report on the basis of compound, type, and end-use:
Compound Outlook (Revenue, USD Million, 2016 - 2028)
Type Outlook (Revenue, USD Million, 2016 - 2028)
Moist Heat Sterilization
End-use Outlook (Revenue, USD Million, 2016 - 2028)
b. The hospital end user segment dominated the Brazil HLD & terminal sterilization services market with a share of 54% in 2020. This is attributable to the large scale of operations and greater funding for bigger medical institutions.
b. Some of the key players operating in the Brazil HLD & terminal sterilization services market include ASP (Fortive), Limpidus, Morhena Group, Steris Plc, Sigex, BSS (Hospitalar), Souza & Filhos, Fonseca Servicos De Outsourcing, Sterigenics U.S., LLC (Sotera Health Company), Getinge AB, Cantel Medical, 3M, Brazil Cleaning Services, Matachana Group, Baumer S. A., CISA Production S.R. L., Mudanjiang Plasma Physical Application Technology Co., Ltd., (CASP), Laoken Technology Co. Ltd., Olympus Corporation, Lifemed, Endoclear, GFE do Brasil, Choyang Medical Industry Ltd., Steelco S.p.A.
b. Key factors that are driving the Brazil HLD & terminal sterilization services market growth include Increasing prevalence of hospital-acquired infections, rising prevalence of chronic diseases, the introduction of technologically advanced products, and growing government initiatives for spreading awareness about cleanliness are few factors driving the market growth
b. The Brazil HLD & terminal sterilization services market size was estimated at USD 1.48 billion in 2020 and is expected to reach USD 1.87 billion in 2021.
b. The Brazil HLD & terminal sterilization services market is expected to grow at a compound annual growth rate of 8.7% from 2021 to 2028 to reach USD 3.36 Billion by 2028.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."